HIGH MYOPIA
Clinical trials for HIGH MYOPIA explained in plain language.
Never miss a new study
Get alerted when new HIGH MYOPIA trials appear
Sign up with your email to follow new studies for HIGH MYOPIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a nightly eye drop tame severe nearsightedness in kids?
Disease control CompletedThis study tested three strengths of atropine eye drops (0.01%, 0.04%, and 0.1%) in 219 children with high myopia (severe nearsightedness). The goal was to see which dose best slows the worsening of vision and eye growth over two years. Children received one drop in each eye ever…
Matched conditions: HIGH MYOPIA
Phase: NA • Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo therapy may slow severe nearsightedness in kids
Disease control CompletedThis study tested whether combining low-dose atropine eye drops with special soft contact lenses can slow the progression of high myopia (severe nearsightedness) in children aged 6-12. 120 children were split into three groups: one got the combo therapy, one got atropine alone wi…
Matched conditions: HIGH MYOPIA
Phase: PHASE4 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could eye pigment levels predict vision damage in severe nearsightedness?
Knowledge-focused CompletedThis study examined 39 people with severe nearsightedness to see if lower levels of a natural eye pigment (macular pigment) are linked to tiny cracks in the back of the eye called lacquer cracks. These cracks can lead to vision loss. The researchers measured the pigment's optical…
Matched conditions: HIGH MYOPIA
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC